Epidemiology of Malignant Melanoma

Melanomas are common cancers arising from the pigment cells of the skin. While in situ and locally invasive melanomas are curable by surgery, advanced disease is difficult to treat and can be lethal, as reflected in the rising mortality rates for these cancers [1]. Population-based strategies to control the disease have largely focused on primary prevention and early detection. For such strategies to be implemented, it is imperative that the underlying epidemiology of melanoma is understood. Emerging evidence from diverse disciplines suggests that melanomas may arise through several different causal pathways; characterizing these pathways is crucially important to developing rational approaches for preventing and treating cutaneous melanoma. The aim of this chapter is to briefly describe the patterns of melanoma occurrence, before reviewing recent discoveries that have changed our understanding of the way in which melanoma arises.

[1]  J. Kładny,et al.  Common variants of DNA repair genes and malignant melanoma. , 2008, European journal of cancer.

[2]  Claus Garbe,et al.  The incidence and mortality of cutaneous melanoma in southern Germany , 2006, Cancer.

[3]  P. Duray,et al.  Neonatal sunburn and melanoma in mice , 2001, Nature.

[4]  J. Barrett,et al.  The effect of sun exposure in determining nevus density in UK adolescent twins. , 2005, The Journal of investigative dermatology.

[5]  Stephen B Gruber,et al.  BRAF and NRAS mutations in melanoma and melanocytic nevi , 2006, Melanoma research.

[6]  P. Boyle,et al.  Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. , 2005, European journal of cancer.

[7]  Lancaster Ho,et al.  Some geographical aspects of the mortality from melanoma in Europeans. , 1956 .

[8]  J. Wikberg,et al.  Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA , 1992, FEBS letters.

[9]  D. English,et al.  Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? , 1995, Journal of the American Academy of Dermatology.

[10]  R. Millikan,et al.  Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study. , 2006, Carcinogenesis.

[11]  K. Kraemer Sunlight and skin cancer: another link revealed. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Verbeek,et al.  An addition to the controversy on sunlight exposure and melanoma risk: a meta-analytical approach. , 1995, Journal of clinical epidemiology.

[13]  S. Franceschi,et al.  Risk of cutaneous melanoma associated with a family history of the disease , 1995, International journal of cancer.

[14]  H. Olsson,et al.  Cutaneous malignant melanoma in South Sweden 1965, 1975, and 1985. A histopathologic review , 1994, Cancer.

[15]  V. Siskind,et al.  Naevi in schoolchildren in Scotland and Australia , 1994, The British journal of dermatology.

[16]  V. Siskind,et al.  Changes in the incidence of cutaneous melanoma in the west of Scotland and Queensland, Australia: hope for health promotion? , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[17]  M. Tucker Is Sunlight Important to Melanoma Causation? , 2008, Cancer Epidemiology Biomarkers & Prevention.

[18]  A. Green,et al.  A theory of site distribution of melanomas: Queensland, Australia , 1992, Cancer Causes & Control.

[19]  D. Pinkel,et al.  MC1R Germline Variants Confer Risk for BRAF-Mutant Melanoma , 2006, Science.

[20]  J. Fraser,et al.  Migration and death from malignant melanoma , 1985, International journal of cancer.

[21]  J. Barrett,et al.  Heritability and gene-environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study. , 2001, The Journal of investigative dermatology.

[22]  J. Lundeberg,et al.  NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing , 2006, Melanoma research.

[23]  Y. Huang,et al.  A meta-analysis of DNA repair gene XPC polymorphisms and cancer risk , 2008, Journal of Human Genetics.

[24]  L. Naldi,et al.  Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma. , 2006, The Journal of investigative dermatology.

[25]  Renato Panizzon,et al.  Overall and site‐specific risk of malignant melanoma associated with nevus counts at different body sites: A multicenter case‐control study of the german central malignant‐melanoma registry , 1995, International journal of cancer.

[26]  V. Siskind,et al.  MOLES IN AUSTRALIAN AND BRITISH SCHOOLCHILDREN , 1988, The Lancet.

[27]  N. Thomas BRAF somatic mutations in malignant melanoma and melanocytic naevi , 2006, Melanoma research.

[28]  J. Bulliard,et al.  Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969-1993. , 2000, International journal of epidemiology.

[29]  M. Viola,et al.  Malignant melanoma in Connecticut and Denmark , 1980, International journal of cancer.

[30]  K. Hou‐Jensen,et al.  Incidence of cutaneous malignant melanoma in Denmark 1978-1982. Anatomic site distribution, histologic types, and comparison with non-melanoma skin cancer. , 1988, British Journal of Cancer.

[31]  F. Sera,et al.  MC1R variants, melanoma and red hair color phenotype: A meta‐analysis , 2008, International journal of cancer.

[32]  R. Millikan,et al.  Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. , 2005, Journal of the National Cancer Institute.

[33]  Lisa M. Schwartz,et al.  Skin biopsy rates and incidence of melanoma: population based ecological study , 2005, BMJ : British Medical Journal.

[34]  Z. Zhuang,et al.  The PTEN tumour suppressor gene and malignant melanoma , 1998, Melanoma research.

[35]  J. Elwood,et al.  Cutaneous melanoma in relation to intermittent and constant sun exposure—the western canada melanoma study , 1985, International journal of cancer.

[36]  R. Gallagher,et al.  Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure , 1998, International journal of cancer.

[37]  R. Winkelmann,et al.  Cutaneous malignant melanoma in Rochester, Minnesota: trends in incidence and survivorship, 1950 through 1985. , 1990, Mayo Clinic proceedings.

[38]  S. Harrison,et al.  Sun exposure and melanocytic naevi in young Australian children , 1994, The Lancet.

[39]  A. Baccarelli,et al.  XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk , 2004, British Journal of Cancer.

[40]  R. MacKie,et al.  Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes. , 2005, The Journal of investigative dermatology.

[41]  G. Colditz,et al.  Risk Factors for Melanoma by Body Site , 2005, Cancer Epidemiology Biomarkers & Prevention.

[42]  T. Holford,et al.  Malignant melanoma risk factors by anatomic site: A case‐control study and polychotomous logistic regression analysis , 1996, International journal of cancer.

[43]  D. Bishop,et al.  Germline mutations of the CDKN2 gene in UK melanoma families. , 1997, Human molecular genetics.

[44]  K. Magnus Habits of sun exposure and risk of malignant melanoma: An analysis of incidence rates in Norway 1955–1977 by cohort, sex, age, and primary tumor site , 1981, Cancer.

[45]  J. Fridlyand,et al.  Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.

[46]  Ian Jackson,et al.  Variants of the melanocyte–stimulating hormone receptor gene are associated with red hair and fair skin in humans , 1995, Nature Genetics.

[47]  M. Coory,et al.  Trends in melanoma mortality in Australia: 1950–2002 and their implications for melanoma control , 2005, Australian and New Zealand journal of public health.

[48]  D. Whiteman,et al.  p53 expression and risk factors for cutaneous melanoma: A case‐control study , 1998, International journal of cancer.

[49]  R. Gallagher Sunbeds--do they increase risk of melanoma or not? , 2005, European journal of cancer.

[50]  J. Bulliard Site‐specific risk of cutaneous malignant melanoma and pattern of Sun exposure in New Zealand , 2000, International journal of cancer.

[51]  R. Hofmann-Wellenhof,et al.  Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis , 2002, Melanoma research.

[52]  M. Cattaruzza,et al.  Sunscreen use, wearing clothes, and number of nevi in 6- to 7-year-old European children. European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. , 1998, Journal of the National Cancer Institute.

[53]  C. Garbe,et al.  Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. , 1992, Journal of the American Academy of Dermatology.

[54]  G. Peters Tumor suppression for ARFicionados: the relative contributions of p16INK4a and p14ARF in melanoma. , 2008, Journal of the National Cancer Institute.

[55]  A. Green,et al.  Cutaneous malignant melanoma in association with other skin cancers. , 1985, Journal of the National Cancer Institute.

[56]  R. Gallagher,et al.  Etiologic and Other Factors Predicting Nevus-Associated Cutaneous Malignant Melanoma , 2005, Cancer Epidemiology Biomarkers & Prevention.

[57]  F. Bray,et al.  Monitoring stage-specific trends in melanoma incidence across Europe reveals the need for more complete information on diagnostic characteristics , 2004, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[58]  A. Dobson,et al.  Mortality from malignant melanoma in Australia: effects due to country of birth. , 1982, International journal of epidemiology.

[59]  M. Tucker,et al.  The Danish case‐control study of cutaneous malignant melanoma. II. Importance of UV‐light exposure , 1988, International journal of cancer.

[60]  V. Giannotti,et al.  Spatial association of melanocytic naevus and melanoma , 1991, Melanoma research.

[61]  I. Jackson,et al.  Melanocortin 1 receptor variants in an Irish population. , 1998, The Journal of investigative dermatology.

[62]  D. Whiteman,et al.  Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies , 2004, Cancer Causes & Control.

[63]  J. Aitken,et al.  Trends for in situ and Invasive Melanoma in Queensland, Australia, 1982–2002 , 2006, Cancer Causes & Control.

[64]  Ajay N. Jain,et al.  Determinants of BRAF mutations in primary melanomas. , 2003, Journal of the National Cancer Institute.

[65]  G. Giles,et al.  Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994 , 1996, BMJ.

[66]  Q. Wei,et al.  Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non‐Hispanic whites in Texas: A case–control study , 2008, International journal of cancer.

[67]  D. Pinkel,et al.  Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. , 2007, The Journal of investigative dermatology.

[68]  Exposure to Artificial Ultraviolet Light. Meeting Exposure to artificial UV radiation and skin cancer , 2006 .

[69]  A. Green,et al.  Mortality from melanoma in migrants to Australia: variation by age at arrival and duration of stay. , 1992, American journal of epidemiology.

[70]  A. Basten,et al.  SCLERODERMA IN CARCINOMA , 1966, The Medical journal of Australia.

[71]  Tim K. Lee,et al.  Tanning Beds, Sunlamps, and Risk of Cutaneous Malignant Melanoma , 2005, Cancer Epidemiology Biomarkers & Prevention.

[72]  M. Skolnick,et al.  Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. , 1992, Science.

[73]  D. Whiteman,et al.  Anatomic site, sun exposure, and risk of cutaneous melanoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[74]  R. Millikan,et al.  Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma , 2007, Cancer Epidemiology Biomarkers & Prevention.

[75]  Florence Demenais,et al.  Geographical variation in the penetrance of CDKN2A mutations for melanoma. , 2002, Journal of the National Cancer Institute.

[76]  M. Berwick,et al.  Epidemiologic support for melanoma heterogeneity using the Surveillance, Epidemiology, and End Results Program. , 2008, The Journal of investigative dermatology.

[77]  W. Lambert,et al.  The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. , 1994, Archives of dermatology.

[78]  J. Rees,et al.  The relation between melanocortin 1 receptor (MC1R) variation and the generation of phenotypic diversity in the cutaneous response to ultraviolet radiation , 2005, Peptides.

[79]  H. Gogas,et al.  Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population. , 2006, The Journal of investigative dermatology.

[80]  J. Mark Elwood,et al.  Melanoma and sun exposure: An overview of published studies , 1997, International journal of cancer.

[81]  L. Naldi,et al.  Sun Exposure, Phenotypic Characteristics, and Cutaneous Malignant Melanoma. An Analysis According to Different Clinico-Pathological Variants and Anatomic Locations (Italy) , 2005, Cancer Causes & Control.

[82]  R. MacKie,et al.  Cutaneous malignant melanoma, Scotland, 1979-89 , 1992, The Lancet.

[83]  M. Berwick,et al.  Epidemiologic support for melanoma heterogeneity using the surveillance, epidemiology, and end results program. , 2008, The Journal of investigative dermatology.

[84]  H. Nelson,et al.  SUNLIGHT AS A CAUSE OF MELANOMA: A CLINICAL SURVEY , 1957, Medical Journal of Australia.

[85]  A Biggeri,et al.  Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study. , 1999, Journal of the American Academy of Dermatology.

[86]  A. Jemal,et al.  Recent trends in cutaneous melanoma incidence among whites in the United States. , 2001, Journal of the National Cancer Institute.

[87]  J. Coebergh,et al.  Cutaneous malignant melanoma in Europe. , 2004, European journal of cancer.

[88]  N. Hayward,et al.  Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma , 1996, Nature Genetics.

[89]  V. Siskind,et al.  A comparison of the anatomic distribution of cutaneous melanoma in two populations with different levels of sunlight: the west of Scotland and Queensland, Australia 1982–2001 , 2007, Cancer Causes & Control.

[90]  S. Harrison,et al.  Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. , 1994, Journal of the American Academy of Dermatology.

[91]  P. Hersey,et al.  An analysis of a melanoma epidemic , 1993, International journal of cancer.

[92]  S. Shuster Is sun exposure a major cause of melanoma? No , 2008, BMJ : British Medical Journal.

[93]  W. Willett,et al.  Moles and site-specific risk of nonfamilial cutaneous malignant melanoma in women. , 1989, Journal of the National Cancer Institute.

[94]  Arjun Chanmugam,et al.  Cutaneous malignant melanoma. , 2006, Mayo Clinic proceedings.

[95]  C. Garbe,et al.  Time trends of cutaneous melanoma in Queensland, Australia and Central Europe , 2000, Cancer.

[96]  B K Armstrong,et al.  Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun? , 1988, The Journal of dermatologic surgery and oncology.

[97]  B. Armstrong,et al.  How much melanoma is caused by sun exposure? , 1993, Melanoma research.

[98]  F. Bray,et al.  Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: Rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia , 2003, International journal of cancer.

[99]  D. Duffy,et al.  CDKN2A variants in a population-based sample of Queensland families with melanoma. , 1999, Journal of the National Cancer Institute.

[100]  J. J. van den Oord,et al.  p16INK4A expression in malignant melanomas with or without a contiguous naevus remnant: a clue to their divergent pathogenesis? , 2004, Melanoma research.

[101]  J. Weber,et al.  Confirmation of chromosome 9p linkage in familial melanoma. , 1993, American journal of human genetics.

[102]  A. Stang,et al.  Site- and gender-specific time trend analyses of the incidence of skin melanomas in the former German Democratic Republic (GDR) including 19351 cases. , 2003, European journal of cancer.

[103]  M. Trivett,et al.  Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma. , 2007, The Journal of investigative dermatology.

[104]  J Cuzick,et al.  Solar keratoses: A risk factor for melanoma but negative association with melanocytic naevi , 1998, International journal of cancer.

[105]  N. Martin,et al.  Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. , 1997, Human molecular genetics.

[106]  D. Easton,et al.  Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: Systematic overview of 10 case‐control studies , 1995 .

[107]  W. Clark,et al.  Germline p16 mutations in familial melanoma , 1994, Nature Genetics.

[108]  J. Rivers Is there more than one road to melanoma? , 2004, The Lancet.

[109]  I. Crombie Variation of melanoma incidence with latitude in North America and Europe. , 1979, British Journal of Cancer.

[110]  C. UNG‐JUURLINK American Academy of Dermatology 1999 Awards for Young Investigators in Dermatology. The prevalence of CDKN2A in patients with atypical nevi and malignant melanoma. , 1999, Journal of the American Academy of Dermatology.

[111]  J F Aitken,et al.  A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. , 1999, American journal of human genetics.

[112]  E. Wynder,et al.  The "over-exposed" control group. , 1992, American journal of epidemiology.

[113]  J. Spinelli,et al.  Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Similarities to melanoma: the Vancouver Mole Study. , 1990, Archives of dermatology.

[114]  B. Armstrong,et al.  Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983–1996 , 2001, International journal of cancer.

[115]  P. Boyle,et al.  Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. , 2005, European journal of cancer.

[116]  J. Gulcher,et al.  CDKN2A mutations and melanoma risk in the Icelandic population , 2008, Journal of Medical Genetics.

[117]  G. Colditz,et al.  Genetic Variation in XPD, Sun Exposure, and Risk of Skin Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[118]  C. Garbe,et al.  Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood , 2003, Cancer.

[119]  T. Holford,et al.  Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site , 1994, Cancer Causes & Control.

[120]  C. la Vecchia,et al.  Incidence of invasive cancers following squamous cell skin cancer. , 1997, American journal of epidemiology.

[121]  P. Hull,et al.  Trends in Invasive Cutaneous Melanoma in Saskatchewan 1970–1999 , 2003, Journal of cutaneous medicine and surgery.

[122]  D. English,et al.  Melanocytic nevi in children. I. Anatomic sites and demographic and host factors. , 1994, American journal of epidemiology.

[123]  J. Bulliard,et al.  Detailed site distribution of melanoma and sunlight exposure: aetiological patterns from a Swiss series. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[124]  K. Magnus Incidence of malignant melanoma of the skin in Norway, 1955–1970. Variations in time and space and solar radiation , 1973, Cancer.

[125]  M. Pollán,et al.  Do sex and site matter? Different age distribution in melanoma of the trunk among Swedish men and women , 2008, The British journal of dermatology.

[126]  Harry L. Arnold,et al.  American Academy of Dermatology , 1980 .

[127]  R. Marks,et al.  DO ALL MELANOMAS COME FROM “MOLES”? A STUDY OF THE HISTOLOGICAL ASSOCIATION BETWEEN MELANOCYTIC NAEVI AND MELANOMA , 1990, The Australasian journal of dermatology.

[128]  J. Bulliard,et al.  Latitude gradients in melanoma incidence and mortality in the non-Maori population of New Zealand , 1994, Cancer Causes & Control.

[129]  N. Martin,et al.  Site distribution of cutaneous melanoma in queensland , 1993, International journal of cancer.

[130]  M. Nicolson,et al.  Incidence of and survival from malignant melanoma in Scotland: an epidemiological study , 2002, The Lancet.

[131]  Sikandar G. Khan,et al.  Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study. , 2005, Carcinogenesis.

[132]  A. Stang,et al.  Time trend analysis of the skin melanoma incidence of Finland from 1953 through 2003 including 16,414 cases , 2006, International journal of cancer.

[133]  Sikandar G. Khan,et al.  No association between three xeroderma pigmentosum group C and one group G gene polymorphisms and risk of cutaneous melanoma , 2005, European Journal of Human Genetics.

[134]  D. Housman,et al.  Molecular definition of a chromosome 9p21 germ-line deletion in a woman with multiple melanomas and a plexiform neurofibroma: implications for 9p tumor-suppressor gene(s). , 1993, American journal of human genetics.

[135]  L. Sandkuijl,et al.  Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds , 1995, Nature Genetics.

[136]  D. Whiteman,et al.  Melanocytic nevi in very young children: the role of phenotype, sun exposure, and sun protection. , 2011, Journal of the American Academy of Dermatology.

[137]  A. Jemal,et al.  Cancer surveillance series: changing patterns of cutaneous malignant melanoma mortality rates among whites in the United States. , 2000, Journal of the National Cancer Institute.

[138]  Forbes Ja Infectious diseases, today and tomorrow. , 1966 .

[139]  D. Lipsker,et al.  Trends in melanoma epidemiology suggest three different types of melanoma , 2007, The British journal of dermatology.

[140]  T. Dwyer,et al.  Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype? , 2004, American journal of epidemiology.

[141]  N. Hayward,et al.  Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. , 2003, Journal of the National Cancer Institute.

[142]  R. Burton,et al.  Recent incidence trends imply a nonmetastasizing form of invasive melanoma , 1994, Melanoma research.

[143]  P. Autier,et al.  Influence of sun exposures during childhood and during adulthood on melanoma risk , 1998, International journal of cancer.